Novel therapeutic strategies in myelodysplastic syndromes
نویسندگان
چکیده
منابع مشابه
[Current treatment strategies for myelodysplastic syndromes].
Myelodysplastic syndromes (MDS) are myeloid clonal disorders presumably induced by genetic mutations in immature hematopoietic cells. According to the international prognostic scoring system (IPSS or IPSS-R), patients are classified into two groups: lower-risk MDS (LR-MDS) and higher-risk MDS (HR-MDS). A majority of LR-MDS patients manifest refractory cytopenias due to inefficient hematopoiesis...
متن کاملMyelodysplastic Syndromes Myelodysplastic syndromes: recent advances
Etiology of myelodysplastic syndromes The models for the development of sporadic MDS suggest the role of cumulative environmental exposures in genetically predisposed individuals. There is increasing evidence for a complex genetic predisposition to MDS involving naturally occurring DNA polymorphisms in genes that mediate DNA repair and metabolize environmental carcinogens.3 Large epidemiologic ...
متن کاملPrognosis and Treatment of Myelodysplastic Syndromes: Novel Therapeutic Strategies BASED ON A PRESENTATION BY ALAN F. LIST, MD
Letter From the Editors W elcome to the 2004 Pharmacy Edition of Frontiers in HematOncology, a report designed to address concerns of the health-system pharmacist. This issue contains a Continuing Education (CE) Program reviewing 2 important symposia—”Prognosis and Treatment of Myelodysplastic Syndromes (MDS),” held at the 2004 Making a Difference in Oncology (MADONC) conference in St Petersbur...
متن کاملMyelodysplastic syndromes.
The myelodysplastic syndromes are a heterogeneous group of hematopoietic stem cell disorders characterized by dysplastic and ineffective hematopoiesis and a varying risk of transformation to acute leukemia. Although the natural history of these syndromes is variable, several factors appear to be of prognostic importance, including the French-American-British classification, the karyotype, in vi...
متن کاملMyelodysplastic syndromes.
These two issues of the Seminars in Hematology will provide the physician the necessary knowledge to help make sense of this somewhat confusing array of diseases. The subdivisions of MDS reflect the precision of our techniques of dissection, with morphological and histochemical analyses forming the foundation to identify and subdivide MDS. Although steady refinement has occurred over the last h...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Opinion in Hematology
سال: 2016
ISSN: 1065-6251
DOI: 10.1097/moh.0000000000000211